Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Orphan Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Orphan Drug market. Detailed analysis of key players, along with key growth strategies adopted by Orphan Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Roche
MERCK
BIOGEN IDEC
GENETHON
BRISTOL MYERS SQUIBB
AOP ORPHAN
GENZYME CORPORATION
Celgene
ELI LILLY
AGENUS
ALEXION
PFIZER
By Type:
Type 1
Type 2
Type 3
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Orphan Drug Market
-
1.3 Market Segment by Type
1.3.1 Japan Orphan Drug Market Size and Growth Rate of Type 1 from 2014 to 2026
1.3.2 Japan Orphan Drug Market Size and Growth Rate of Type 2 from 2014 to 2026
1.3.3 Japan Orphan Drug Market Size and Growth Rate of Type 3 from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Orphan Drug Market Size and Growth Rate of Application 1 from 2014 to 2026
1.4.2 Japan Orphan Drug Market Size and Growth Rate of Application 2 from 2014 to 2026
1.4.3 Japan Orphan Drug Market Size and Growth Rate of Application 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Orphan Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Orphan Drug by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Orphan Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Orphan Drug by Major End-Users
4.4.1 Market Size and Growth Rate of Orphan Drug in Application 1
4.4.2 Market Size and Growth Rate of Orphan Drug in Application 2
4.4.3 Market Size and Growth Rate of Orphan Drug in Application 3
5 Market Analysis by Regions
-
5.1 Japan Orphan Drug Production Analysis by Regions
-
5.2 Japan Orphan Drug Consumption Analysis by Regions
6 Hokkaido Orphan Drug Landscape Analysis
-
6.1 Hokkaido Orphan Drug Landscape Analysis by Major Types
-
6.2 Hokkaido Orphan Drug Landscape Analysis by Major End-Users
7 Tohoku Orphan Drug Landscape Analysis
-
7.1 Tohoku Orphan Drug Landscape Analysis by Major Types
-
7.2 Tohoku Orphan Drug Landscape Analysis by Major End-Users
8 Kanto Orphan Drug Landscape Analysis
-
8.1 Kanto Orphan Drug Landscape Analysis by Major Types
-
8.2 Kanto Orphan Drug Landscape Analysis by Major End-Users
9 Chubu Orphan Drug Landscape Analysis
-
9.1 Chubu Orphan Drug Landscape Analysis by Major Types
-
9.2 Chubu Orphan Drug Landscape Analysis by Major End-Users
10 Kinki Orphan Drug Landscape Analysis
-
10.1 Kinki Orphan Drug Landscape Analysis by Major Types
-
10.2 Kinki Orphan Drug Landscape Analysis by Major End-Users
11 Chugoku Orphan Drug Landscape Analysis
-
11.1 Chugoku Orphan Drug Landscape Analysis by Major Types
-
11.2 Chugoku Orphan Drug Landscape Analysis by Major End-Users
12 Shikoku Orphan Drug Landscape Analysis
-
12.1 Shikoku Orphan Drug Landscape Analysis by Major Types
-
12.2 Shikoku Orphan Drug Landscape Analysis by Major End-Users
13 Kyushu Orphan Drug Landscape Analysis
-
13.1 Kyushu Orphan Drug Landscape Analysis by Major Types
-
13.2 Kyushu Orphan Drug Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Roche
14.1.1 Roche Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 MERCK
14.2.1 MERCK Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 BIOGEN IDEC
14.3.1 BIOGEN IDEC Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 GENETHON
14.4.1 GENETHON Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 BRISTOL MYERS SQUIBB
14.5.1 BRISTOL MYERS SQUIBB Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 AOP ORPHAN
14.6.1 AOP ORPHAN Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 GENZYME CORPORATION
14.7.1 GENZYME CORPORATION Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Celgene
14.8.1 Celgene Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 ELI LILLY
14.9.1 ELI LILLY Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 AGENUS
14.10.1 AGENUS Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 ALEXION
14.11.1 ALEXION Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 PFIZER
14.12.1 PFIZER Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
The List of Tables and Figures (Totals 124 Figures and 188 Tables)
Figure Japan Orphan Drug Market Size and Growth Rate of Type 1 from 2014 to 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Type 2 from 2014 to 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Type 3 from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Orphan Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Orphan Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Orphan Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Orphan Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Orphan Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Orphan Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Orphan Drug by Different End-Users from 2014 to 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Orphan Drug Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Table Japan Orphan Drug Production by Regions
-
Table Japan Orphan Drug Production Share by Regions
-
Figure Japan Orphan Drug Production Share by Regions in 2014
-
Figure Japan Orphan Drug Production Share by Regions in 2018
-
Figure Japan Orphan Drug Production Share by Regions in 2026
-
Table Japan Orphan Drug Consumption by Regions
-
Table Japan Orphan Drug Consumption Share by Regions
-
Figure Japan Orphan Drug Consumption Share by Regions in 2014
-
Figure Japan Orphan Drug Consumption Share by Regions in 2018
-
Figure Japan Orphan Drug Consumption Share by Regions in 2026
-
Table Hokkaido Orphan Drug Consumption by Types from 2014 to 2026
-
Table Hokkaido Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Orphan Drug Consumption Share by Types in 2014
-
Figure Hokkaido Orphan Drug Consumption Share by Types in 2018
-
Figure Hokkaido Orphan Drug Consumption Share by Types in 2026
-
Table Hokkaido Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Orphan Drug Consumption Share by End-Users in 2014
-
Figure Hokkaido Orphan Drug Consumption Share by End-Users in 2018
-
Figure Hokkaido Orphan Drug Consumption Share by End-Users in 2026
-
Table Tohoku Orphan Drug Consumption by Types from 2014 to 2026
-
Table Tohoku Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Orphan Drug Consumption Share by Types in 2014
-
Figure Tohoku Orphan Drug Consumption Share by Types in 2018
-
Figure Tohoku Orphan Drug Consumption Share by Types in 2026
-
Table Tohoku Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Tohoku Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Orphan Drug Consumption Share by End-Users in 2014
-
Figure Tohoku Orphan Drug Consumption Share by End-Users in 2018
-
Figure Tohoku Orphan Drug Consumption Share by End-Users in 2026
-
Table Kanto Orphan Drug Consumption by Types from 2014 to 2026
-
Table Kanto Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Kanto Orphan Drug Consumption Share by Types in 2014
-
Figure Kanto Orphan Drug Consumption Share by Types in 2018
-
Figure Kanto Orphan Drug Consumption Share by Types in 2026
-
Table Kanto Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Kanto Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Orphan Drug Consumption Share by End-Users in 2014
-
Figure Kanto Orphan Drug Consumption Share by End-Users in 2018
-
Figure Kanto Orphan Drug Consumption Share by End-Users in 2026
-
Table Chubu Orphan Drug Consumption by Types from 2014 to 2026
-
Table Chubu Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Chubu Orphan Drug Consumption Share by Types in 2014
-
Figure Chubu Orphan Drug Consumption Share by Types in 2018
-
Figure Chubu Orphan Drug Consumption Share by Types in 2026
-
Table Chubu Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Chubu Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Orphan Drug Consumption Share by End-Users in 2014
-
Figure Chubu Orphan Drug Consumption Share by End-Users in 2018
-
Figure Chubu Orphan Drug Consumption Share by End-Users in 2026
-
Table Kinki Orphan Drug Consumption by Types from 2014 to 2026
-
Table Kinki Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Kinki Orphan Drug Consumption Share by Types in 2014
-
Figure Kinki Orphan Drug Consumption Share by Types in 2018
-
Figure Kinki Orphan Drug Consumption Share by Types in 2026
-
Table Kinki Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Kinki Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Orphan Drug Consumption Share by End-Users in 2014
-
Figure Kinki Orphan Drug Consumption Share by End-Users in 2018
-
Figure Kinki Orphan Drug Consumption Share by End-Users in 2026
-
Table Chugoku Orphan Drug Consumption by Types from 2014 to 2026
-
Table Chugoku Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Orphan Drug Consumption Share by Types in 2014
-
Figure Chugoku Orphan Drug Consumption Share by Types in 2018
-
Figure Chugoku Orphan Drug Consumption Share by Types in 2026
-
Table Chugoku Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Chugoku Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Orphan Drug Consumption Share by End-Users in 2014
-
Figure Chugoku Orphan Drug Consumption Share by End-Users in 2018
-
Figure Chugoku Orphan Drug Consumption Share by End-Users in 2026
-
Table Shikoku Orphan Drug Consumption by Types from 2014 to 2026
-
Table Shikoku Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Orphan Drug Consumption Share by Types in 2014
-
Figure Shikoku Orphan Drug Consumption Share by Types in 2018
-
Figure Shikoku Orphan Drug Consumption Share by Types in 2026
-
Table Shikoku Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Shikoku Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Orphan Drug Consumption Share by End-Users in 2014
-
Figure Shikoku Orphan Drug Consumption Share by End-Users in 2018
-
Figure Shikoku Orphan Drug Consumption Share by End-Users in 2026
-
Table Kyushu Orphan Drug Consumption by Types from 2014 to 2026
-
Table Kyushu Orphan Drug Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Orphan Drug Consumption Share by Types in 2014
-
Figure Kyushu Orphan Drug Consumption Share by Types in 2018
-
Figure Kyushu Orphan Drug Consumption Share by Types in 2026
-
Table Kyushu Orphan Drug Consumption by End-Users from 2014 to 2026
-
Table Kyushu Orphan Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Orphan Drug Consumption Share by End-Users in 2014
-
Figure Kyushu Orphan Drug Consumption Share by End-Users in 2018
-
Figure Kyushu Orphan Drug Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
Figure Sales and Growth Rate Analysis of Roche
Figure Revenue and Market Share Analysis of Roche
Table Product and Service Introduction of Roche
Table Company Profile and Development Status of MERCK
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MERCK
Figure Sales and Growth Rate Analysis of MERCK
Figure Revenue and Market Share Analysis of MERCK
Table Product and Service Introduction of MERCK
Table Company Profile and Development Status of BIOGEN IDEC
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOGEN IDEC
Figure Sales and Growth Rate Analysis of BIOGEN IDEC
Figure Revenue and Market Share Analysis of BIOGEN IDEC
Table Product and Service Introduction of BIOGEN IDEC
Table Company Profile and Development Status of GENETHON
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GENETHON
Figure Sales and Growth Rate Analysis of GENETHON
Figure Revenue and Market Share Analysis of GENETHON
Table Product and Service Introduction of GENETHON
Table Company Profile and Development Status of BRISTOL MYERS SQUIBB
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BRISTOL MYERS SQUIBB
Figure Sales and Growth Rate Analysis of BRISTOL MYERS SQUIBB
Figure Revenue and Market Share Analysis of BRISTOL MYERS SQUIBB
Table Product and Service Introduction of BRISTOL MYERS SQUIBB
Table Company Profile and Development Status of AOP ORPHAN
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AOP ORPHAN
Figure Sales and Growth Rate Analysis of AOP ORPHAN
Figure Revenue and Market Share Analysis of AOP ORPHAN
Table Product and Service Introduction of AOP ORPHAN
Table Company Profile and Development Status of GENZYME CORPORATION
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GENZYME CORPORATION
Figure Sales and Growth Rate Analysis of GENZYME CORPORATION
Figure Revenue and Market Share Analysis of GENZYME CORPORATION
Table Product and Service Introduction of GENZYME CORPORATION
Table Company Profile and Development Status of Celgene
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
Figure Sales and Growth Rate Analysis of Celgene
Figure Revenue and Market Share Analysis of Celgene
Table Product and Service Introduction of Celgene
Table Company Profile and Development Status of ELI LILLY
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ELI LILLY
Figure Sales and Growth Rate Analysis of ELI LILLY
Figure Revenue and Market Share Analysis of ELI LILLY
Table Product and Service Introduction of ELI LILLY
Table Company Profile and Development Status of AGENUS
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AGENUS
Figure Sales and Growth Rate Analysis of AGENUS
Figure Revenue and Market Share Analysis of AGENUS
Table Product and Service Introduction of AGENUS
Table Company Profile and Development Status of ALEXION
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALEXION
Figure Sales and Growth Rate Analysis of ALEXION
Figure Revenue and Market Share Analysis of ALEXION
Table Product and Service Introduction of ALEXION
Table Company Profile and Development Status of PFIZER
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PFIZER
Figure Sales and Growth Rate Analysis of PFIZER
Figure Revenue and Market Share Analysis of PFIZER
Table Product and Service Introduction of PFIZER
-
